Consolidated Balance Sheets - USD ($) $ in Thousands	Jan. 31, 2023	Jan. 31, 2022
Current assets:
Cash and cash equivalents	$ 264,162	$ 315,235
Restricted cash	30,400	400
Short-term investments	104,966	0
Accounts receivable, net of allowance of $10,000 as of January 31, 2023 and $5,584 as of January 31, 2022	164,892	75,939
Inventories	68,730	35,879
Prepaid expenses and other current assets	71,020	36,603
Total current assets	704,170	464,056
Property and equipment, net	40,046	34,593
Intangible assets, net	92,673	107,209
Operating Lease, Right-of-Use Asset	22,242	25,535
Goodwill	213,716	218,484
Other assets	7,110	6,020
Total assets	1,079,957	855,897
Current liabilities:
Accounts payable	62,076	27,576
Accrued and other current liabilities	133,483	84,328
Deferred revenue	88,777	77,142
Total current liabilities	284,336	189,046
Deferred revenue, noncurrent	109,833	69,666
Debt, noncurrent	294,936	0
Operating lease liabilities	21,841	25,370
Deferred tax liabilities	12,987	17,697
Other long-term liabilities	1,032	7,104
Total liabilities	724,965	308,883
Commitments and contingencies
Temporary Equity [Abstract]
Redeemable convertible preferred stock: $0.0001 par value; zero and — shares authorized as of January 31, 2023 and 2022, respectively; zero and — shares issued and outstanding as of January 31, 2023 and 2022, respectively (liquidation value: nil and $— as of January 31, 2023 and 2022, respectively)	0	0
Stockholders' equity:
Common stock: $0.0001 par value; 1,000,000,000 shares authorized as of each of January 31, 2023 and 2022; 348,330,481 and 334,760,615 shares issued and outstanding as of January 31, 2023 and 2022, respectively	35	33
Preferred stock, $0.0001 par value; 10,000,000 shares authorized as of each of January 31, 2023 and 2022; zero shares issued and outstanding as of each of January 31, 2023 and 2022	0	0
Additional paid-in capital	1,528,104	1,366,855
Accumulated other comprehensive income (loss)	(16,384)	(8,219)
Accumulated deficit	(1,156,763)	(811,655)
Total stockholders' equity	354,992	547,014
Total liabilities and stockholders' equity	$ 1,079,957	$ 855,897
Preferred stock, shares authorized (in shares)	10,000,000	10,000,000
Common stock, shares authorized (in shares)	1,000,000,000	1,000,000,000